FundComb

Investment and M&A transaction comps

Healthcare Investment & M&A Transaction Comps

Healthcare services, healthcare IT, medtech, diagnostics, life sciences tools and related healthcare transactions. Pure biotech rows are tracked separately where normal revenue multiples are less meaningful.

Consumer CPG Beauty Supplements Food & Beverage Healthcare
16
Reviewed transactions
5
With price data
4.8x
Median EV or valuation / revenue
11.0x
Median EV or valuation / EBITDA
Year Transactions Priced Median EV or valuation / revenue Median EV or valuation / EBITDA
2026 6 1 - -

Sortable transaction comps

Healthcare transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

5 / 16

Acquisition EV, USD

USD 15B

Investment EV, USD

-

Median EV / revenue

4.8x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

16 shown of 16 matching transactions. Click any transaction row for more detail.

Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.

Select for comparison
2026-07-31 Lallemand Inc. Undisclosed - -
HealthcareDietary Supplements
+4
EnzymesHealth IngredientsMicrobial IngredientsProbiotics
2026-07-27 American Industrial Partners Undisclosed - -
HealthcareMedtech
+1
Medical Devices
2026-07-13 Servier Undisclosed - -
BiotechMuscular Dystrophy
+2
PharmaTherapeutics
2026-07-06 Altaris LLC 600 - -
HealthcareLife Sciences
+3
Healthcare Data And AnalyticsInformation ServicesLife Sciences Information Services
2026-05-27 HCA Healthcare Undisclosed - -
HealthcareHealthcare Services
+1
Healthcare Education
Tubulis
Control
 2026-05-21 Gilead Sciences Undisclosed - -
BiotechAntibody Drug Conjugates
+2
OncologyTherapeutics
2021-10-11 Pacira BioSciences Undisclosed - 11.0x
Life SciencesConsumer
+2
Joint Pain TherapiesNon Opioid Pain Therapeutics
2020-08-31 Sociétés des Produits Nestlé S.A. / Nestlé Health Science 2,600 - -
BiotechBiopharmaceuticals
+3
Food Allergy TherapeuticsPeanut Allergy TherapyTherapeutics
VCA Inc.
Control (100%)
 2017-01-09 Mars, Incorporated 9,100 3.6x -
HealthcareConsumer
+2
PetVeterinary Healthcare Services
- GE HealthCare 945 - -
DiagnosticsHealthcare
+4
MedtechContract ManufacturingRadiopharmaceutical ManufacturingRadiopharmaceuticals
Vyne Medical
Control
 - MRO Undisclosed - -
HealthcareClinical Data Management
+3
Document WorkflowHealth Information ExchangeHealthcare Software
- CoreHealth Technologies Undisclosed - -
HealthcareEmployee Wellness
+4
Managed ServicesPlatform AdministrationWellness Program DeliveryWorkplace Wellness
- Telix Pharmaceuticals Limited 1,650 6.0x -
BiotechDrug Development
+2
Radioisotope ManufacturingRadiopharmaceuticals
- Funds managed by Blue Owl Capital Undisclosed - -
HealthcareHealthcare Real Estate
E-Pharma Trento
Control (100%)
 - Wise Equity Undisclosed - -
HealthcarePharma
+1
Pharmaceutical Manufacturing
- Knox Lane Undisclosed - -
HealthcareHealthcare Staffing
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.